| Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug M Razmi, A Divsalar, AA Saboury, Z Izadi, T Haertlé, H Mansuri-Torshizi Colloids and Surfaces B: Biointerfaces 112, 362-367, 2013 | 47 | 2013 |
| Biological evaluation of a new synthesized Pt (II) complex by cytotoxic and spectroscopic studies A Divsalar, M Razmi, AA Saboury, H Mansouri-Torshizi, F Ahmad Cell biochemistry and biophysics 71, 1415-1424, 2015 | 43 | 2015 |
| Synergy of theophylline reduces necrotic effect of berberine, induces cell cycle arrest and PARP, HMGB1, Bcl-2 family mediated apoptosis in MDA-MB-231 breast cancer cells F Hashemi-Niasari, A Rabbani-Chadegani, M Razmi, S Fallah Biomedicine & Pharmacotherapy 106, 858-867, 2018 | 34 | 2018 |
| Periostin: biology and function in cancer S Dorafshan, M Razmi, S Safaei, E Gentilin, Z Madjd, R Ghods Cancer Cell International 22 (1), 315, 2022 | 30 | 2022 |
| Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis M Razmi, R Ghods, S Vafaei, M Sahlolbei, L Saeednejad Zanjani, ... Cancer Cell International 21, 1-20, 2021 | 26 | 2021 |
| Biomaterials in valvular heart diseases B Taghizadeh, L Ghavami, H Derakhshankhah, E Zangene, M Razmi, ... Frontiers in Bioengineering and Biotechnology 8, 529244, 2020 | 26 | 2020 |
| Spotlight of remdesivir in comparison with ribavirin, favipiravir, oseltamivir and umifenovir in coronavirus disease 2019 (COVID-19) pandemic S Vafaei, M Razmi, M Mansoori, M Asadi-Lari, Z Madjd Favipiravir, Oseltamivir and Umifenovir in Coronavirus Disease, 2019 | 23 | 2019 |
| The design and characterization of a novel beta-casein nano-vehicle loaded with platinum anticancer drug for drug delivery A Divsalar, M Razmi, A Akbar Saboury, A Seyedarabi Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2014 | 18 | 2014 |
| Cytotoxic and spectroscopic studies on binding of a new synthesized bipyridine ethyl dithiocarbamate Pt (II) nitrate complex to the milk carrier protein of BLG A Divsalar, I Zhila, AA Saboury, M Nabiuni, M Razmi, H Mansuri-Torshizi Journal of the Iranian Chemical Society 10, 951-959, 2013 | 18 | 2013 |
| Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review M Razmi, F Hashemi, E Gheytanchi, MD Manshadi, R Ghods, Z Madjd International Immunopharmacology 88, 106942, 2020 | 16 | 2020 |
| Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer M Mohsenzadegan, M Razmi, S Vafaei, M Abolhasani, Z Madjd, ... Scientific reports 12 (1), 599, 2022 | 13 | 2022 |
| Immunoengineering Biomaterials in Cell-based therapy for type 1 diabetes H Derakhshankhah, S Sajadimajd, F Jahanshahi, Z Samsonchi, H Karimi, ... Tissue Engineering Part B: Reviews 28 (5), 1053-1066, 2022 | 11 | 2022 |
| Lithium chloride attenuates mitomycin C induced necrotic cell death in MDA-MB-231 breast cancer cells via HMGB1 and Bax signaling M Razmi, A Rabbani-Chadegani, F Hashemi-Niasari, P Ghadam Journal of Trace Elements in Medicine and Biology 48, 87-96, 2018 | 10 | 2018 |
| Efficacy of whole cancer stem cell-based vaccines: a systematic review of preclinical and clinical studies F Hashemi, M Razmi, F Tajik, M Zöller, M Dehghan Manshadi, ... Stem Cells 41 (3), 207-232, 2023 | 9 | 2023 |
| Cytoplasmic expression of DCLK1-S, a novel DCLK1 isoform, is associated with tumor aggressiveness and worse disease-specific survival in colorectal cancer E Kalantari, R Ghods, L Saeednejad Zanjani, M Rahimi, L Eini, M Razmi, ... Cancer Biomarkers 33 (3), 277-289, 2022 | 8 | 2022 |
| Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: A systematic review and meta-analysis E Kalantari, M Razmi, F Tajik, M Asadi-Lari, R Ghods, Z Madjd Cancer Cell International 22 (1), 217, 2022 | 7 | 2022 |
| Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis E Gheytanchi, F Tajik, M Razmi, S Babashah, WCS Cho, K Tanha, ... Cancer Cell International 23 (1), 10, 2023 | 4 | 2023 |
| Overexpression of cytoplasmic dynamin 2 is associated with worse outcomes in patients with clear cell renal cell carcinoma S Safaei, R Sajed, L Saeednejad Zanjani, M Rahimi, F Fattahi, ... Cancer Biomarkers 35 (1), 27-45, 2022 | 4 | 2022 |
| Clinical prognostic value of the SMYD2/3 as new epigenetic biomarkers in solid cancer patients: a systematic review and meta-analysis M Razmi, A Yazdanpanah, S Etemad-Moghadam, M Alaeddini, S Angelini, ... Expert Review of Molecular Diagnostics 22 (10), 937-951, 2022 | 2 | 2022 |
| Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progression L Saeednejad Zanjani, M Razmi, F Fattahi, E Kalantari, M Abolhasani, ... Journal of Cancer Research and Clinical Oncology 148 (3), 609-631, 2022 | 2 | 2022 |
Zahra MadjdProfessor, Dep pathology and Head, Dep Molecular Medicine Iran University of Medical sciences在 iums.ac.ir 的电子邮件经过验证
